Welcome to our dedicated page for Hims & Hers Health SEC filings (Ticker: HIMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hims & Hers Health, Inc. filings document the regulatory record for a public consumer telehealth company offering access to health-and-wellness treatments through its digital platform. Its disclosures include operating and financial results, shareholder letters, material-event reports and clinical or regulatory updates related to products and services available through the platform, including weight loss care.
Proxy and 8-K filings cover board elections, executive compensation, shareholder voting matters, governance practices and capital-structure disclosures. The filing record also documents Class A common stock matters, share repurchase authorizations, material agreements, Regulation FD disclosures and other events affecting the company’s public-company reporting obligations.
Hims & Hers Health Chief Medical Officer Patrick Harrison reported routine equity compensation activity. On June 15, 2026, he acquired 25,926 shares of Class A Common Stock through the vesting and settlement of Restricted Stock Units (RSUs). To cover related tax withholding obligations, 8,310 shares were withheld by the company rather than sold on the open market.
Following these transactions, Harrison directly held 213,897 shares of Class A Common Stock. The RSUs vest under multi‑year, service-based schedules, with portions vesting on company quarterly vesting dates through future years.
Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe reported compensation-related equity activity involving Class A Common Stock and Restricted Stock Units (RSUs). On June 15, 2026, RSUs were exercised to deliver 71,616 shares of Class A Common Stock, reflecting vesting under prior equity awards. To cover associated tax withholding obligations, 39,541 shares of Class A Common Stock were withheld by the company at $30.17 per share, rather than sold on the open market. Following these transactions, Okupe directly held 296,142 shares of Class A Common Stock and indirectly held 7,853 shares through the Oluyemi Okupe Separate Property Trust dated September 1, 2021. The footnotes explain that each RSU converts into one share of Class A Common Stock and that the RSUs vest in substantially equal quarterly installments over four years, with first vesting dates ranging from June 15, 2023 to June 15, 2026.
Hims & Hers Health, Inc. Chief Policy Officer Deborah M. Autor reported routine equity compensation activity involving restricted stock units (RSUs). On June 15, 2026, 32,919 RSUs converted into an equal number of Class A Common shares. Of these, 15,396 shares were withheld at a price of $30.17 per share to cover tax obligations, leaving her with 48,961 Class A Common shares held directly after the transactions. Following the RSU conversion, she also held 460,873 RSUs, which carry a service-based vesting schedule over four years, vesting in substantially equal quarterly installments beginning on March 15, 2026.
Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported multiple equity transactions involving Class A Common Stock and Restricted Stock Units. He exercised awards covering 86,264 shares of common stock on June 15, 2026, converting RSUs into shares at a stated price of $0.00 per share.
To cover tax obligations from these vestings, 47,699 shares of Class A Common Stock were withheld by the company at $30.17 per share. On June 17, 2026, he executed an open-market sale of 14,027 shares at $31.50 per share under a pre-arranged Rule 10b5-1 trading plan.
Following these transactions, Chi directly owns 432,124 shares of Class A Common Stock. The RSUs are subject to four-year, service-based vesting in substantially equal quarterly installments under the company’s standard vesting schedules.
Hims & Hers Health, Inc. Principal Accounting Officer Irene Becklund reported a series of stock transactions tied to equity compensation. On June 15, 2026, she exercised awards and acquired 15,971 shares of Class A Common Stock as Restricted Stock Units vested.
Of these, 5,870 shares were withheld by the company to cover tax obligations related to the RSU vesting. She then sold 7,573 shares at $30.25 per share on June 16, 2026 and 4,490 shares at $31.50 per share on June 17, 2026, with both sales executed under a pre-arranged Rule 10b5-1 trading plan. After these transactions, she directly holds 6,790 shares of Class A Common Stock.
Hims & Hers Health, Inc. Chief Legal Officer Soleil Boughton reported routine equity compensation activity linked to restricted stock units (RSUs). On June 15, 2026, RSUs converted into 42,261 shares of Class A Common Stock, while 23,315 shares were withheld by the company to cover tax obligations. After these transactions, Boughton held 341,629 Class A shares directly, reflecting continued equity ownership rather than an open-market sale.
Hims & Hers Health Chief Executive Officer Andrew Dudum reported routine equity compensation activity involving Restricted Stock Units (RSUs). On June 15, 2026, he exercised RSUs covering 154,991 shares of Class A Common Stock at a conversion price of $0.00 per share.
To satisfy tax obligations tied to this vesting and settlement, 85,632 shares of Class A Common Stock were withheld by the company at $30.17 per share. Following these transactions, Dudum directly held 957,043 shares of Class A Common Stock and maintained additional indirect holdings through various family trusts, including 3,004,071 shares held by the Trustee of the Dudum Family 2021 Trust.
Hims & Hers Health, Inc. CTO Mohamed Elshenawy reported multiple equity transactions. He exercised derivative awards into 282,597 shares of Class A Common Stock on June 15, 2026, alongside RSU conversions totaling 282,597 underlying shares. On the same date, 151,534 shares were withheld by the company to cover tax obligations from RSU vesting. On June 17, 2026, he made an open-market sale of 30,040 shares at $31.50 per share under a pre-arranged Rule 10b5-1 trading plan, leaving him with 101,023 shares of Class A Common Stock held directly.
Filer submitted Form 144 reporting proposed sales of Class A shares. The excerpt lists restricted stock vesting events of 4,019 shares on 06/15/2026 and 471 shares on 03/15/2026, and two proposed sales by Irene Becklund: 5,529 shares on 03/17/2026 and 7,573 shares on 06/16/2026.